OR WAIT null SECS
June 06, 2019
CPI, has supported a project focused on developing and integrating novel recombinant prokaryotic lectins (RPLs) into a biosensor-based platform.
Gene therapy development company, bluebird bio, has revealed that the European Commission has granted conditional marketing authorization for Zynteglo.
May 31, 2019
Prestige BioPharma has announced that the EMA has accepted its marketing authorization application for HD201 (Tuzune) for review.
Cannuba has announced that it is collaborating with an independent scientific body on drugs from the UK on the launch of a medical cannabis working group.
CDMO, Vibalogics, has revealed that it will be acquired by a private equity firm, Ampersand Capital Partners.
ABPI has issued a response to the recent publication of the UK's Migration Advisory Committee’s full review on the shortage occupation list.
May 22, 2019
Cegedim, has announced that it is collaborating with Sanofi to deliver real-world data for the improvement of health within Europe.
Medherant has announced that it is the recipient of a new £2-million (US$2.5-million) investment from Mercia Technologies.
May 21, 2019
The agency updated its list of recommended influenza virus strains that manufacturers should include in vaccines for the autumn 2019 season.
May 17, 2019
The agency is reviewing Xeljanz (tofacitinib) because of the risk of blood clots in the lungs.